Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 45

1.

HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies.

Frange P, Assoumou L, Descamps D, Chéret A, Goujard C, Tran L, Gousset M, Avettand-Fenoël V, Bocket L, Fafi-Kremer S, Guinard J, Morand-Joubert L, Nicot F, Plantier JC, Rogez S, Wirden M, Rouzioux C, Meyer L, Chaix ML; French ANRS CO 6 PRIMO Cohort, the ANRS 147 OPTIPRIM Clinical Trial and the AC11 Resistance Study Groups; French ANRS CO 6 PRIMO Cohort the ANRS 147 OPTIPRIM Clinical Trial and the AC11 Resistance Study Groups.

J Antimicrob Chemother. 2015 Jul;70(7):2084-9. doi: 10.1093/jac/dkv049. Epub 2015 Feb 26.

PMID:
25885327
2.

Virological failure of patients on maraviroc-based antiretroviral therapy.

Raymond S, Maillard A, Amiel C, Peytavin G, Trabaud MA, Desbois D, Bellecave P, Delaugerre C, Soulie C, Marcelin AG, Descamps D, Izopet J; on behalf the ANRS AC11 Resistance Study Group.

J Antimicrob Chemother. 2015 Jun;70(6):1858-64. doi: 10.1093/jac/dkv026. Epub 2015 Feb 19.

PMID:
25700719
3.

Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients.

Fourati S, Charpentier C, Amiel C, Morand-Joubert L, Reigadas S, Trabaud MA, Delaugerre C, Nicot F, Rodallec A, Maillard A, Mirand A, Jeulin H, Montès B, Barin F, Bettinger D, Le Guillou-Guillemette H, Vallet S, Signori-Schmuck A, Descamps D, Calvez V, Flandre P, Marcelin AG; ANRS AC11 Resistance Study Group.

J Antimicrob Chemother. 2015 May;70(5):1507-12. doi: 10.1093/jac/dku535. Epub 2015 Jan 3.

PMID:
25558077
4.

Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma.

Soulie C, Descamps D, Grudé M, Schneider V, Trabaud MA, Morand-Joubert L, Delaugerre C, Montes B, Barin F, Ferre V, Raymond S, Jeulin H, Alloui C, Yerly S, Pallier C, Reigadas S, Signori-Schmuck A, Guigon A, Fafi-Kremer S, Haïm-Boukobza S, Mirand A, Maillard A, Vallet S, Roussel C, Assoumou L, Calvez V, Flandre P, Marcelin AG; ANRS Resistance AC11 Group.

J Antimicrob Chemother. 2015 Feb;70(2):566-72. doi: 10.1093/jac/dku419. Epub 2014 Oct 25.

PMID:
25344810
5.

Persistent production of an integrase-deleted HIV-1 variant with no resistance mutation and wild-type proviral DNA in a treated patient.

Trabaud MA, Cotte L, Saison J, Ramière C, Ronfort C, Venet F, Tardy JC, Monneret G, André P.

AIDS Res Hum Retroviruses. 2015 Jan;31(1):142-9. doi: 10.1089/AID.2014.0129.

PMID:
25333615
6.

National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.

Descamps D, Assoumou L, Chaix ML, Chaillon A, Pakianather S, de Rougemont A, Storto A, Dos Santos G, Krivine A, Delaugerre C, Montes B, Izopet J, Charpentier C, Wirden M, Maillard A, Morand-Joubert L, Pallier C, Plantier JC, Guinard J, Tamalet C, Cottalorda J, Marcelin AG, Desbois D, Henquell C, Calvez V, Brun-Vézinet F, Masquelier B, Costagliola D; ANRS AC11 Resistance Study Group.

J Antimicrob Chemother. 2013 Nov;68(11):2626-31. doi: 10.1093/jac/dkt238. Epub 2013 Jun 24.

7.

Low-level viremia is associated with non-B subtypes in patients infected with HIV with virological success following HAART introduction.

Saison J, Tardy JC, Scholtes C, Icard V, Trabaud MA, Perpoint T, Chidiac C, Ecochard R, André P, Ferry T; Lyon HIV Cohort Study.

J Med Virol. 2013 Jun;85(6):953-8. doi: 10.1002/jmv.23553.

PMID:
23588720
8.

A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure.

Marcelin AG, Delaugerre C, Beaudoux C, Descamps D, Morand-Joubert L, Amiel C, Schneider V, Ferre V, Izopet J, Si-Mohamed A, Maillard A, Henquell C, Desbois D, Lazrek M, Signori-Schmuck A, Rogez S, Yerly S, Trabaud MA, Plantier JC, Fourati S, Houssaini A, Masquelier B, Calvez V, Flandre P; ANRS AC11 Resistance Group.

Int J Antimicrob Agents. 2013 Jul;42(1):42-7. doi: 10.1016/j.ijantimicag.2013.02.016. Epub 2013 Apr 4.

PMID:
23562640
9.

Real-life evaluation of a human immunodeficiency virus screening algorithm using a single combined p24 antigen-antibody assay.

Fanmi AN, Ramière C, Tardy JC, André P.

Eur J Clin Microbiol Infect Dis. 2013 Mar;32(3):425-30. doi: 10.1007/s10096-012-1760-1. Epub 2012 Oct 23.

PMID:
23090728
10.

CD4+CD25+CD127- assessment as a surrogate phenotype for FOXP3+ regulatory T cells in HIV-1 infected viremic and aviremic subjects.

Saison J, Demaret J, Venet F, Chidiac C, Malcus C, Poitevin-Later F, Tardy JC, Ferry T, Monneret G.

Cytometry B Clin Cytom. 2013 Jan-Feb;84(1):50-4. doi: 10.1002/cyto.b.21047. Epub 2012 Sep 27.

11.

HIV-1 Subtype distribution in morocco based on national sentinel surveillance data 2004-2005.

Akrim M, Lemrabet S, Elharti E, Gray RR, Tardy JC, Cook RL, Salemi M, Andre P, Azarian T, Aouad RE.

AIDS Res Ther. 2012 Feb 14;9(1):5. doi: 10.1186/1742-6405-9-5.

12.

Discordance in HIV-1 co-receptor use prediction by different genotypic algorithms and phenotype assay: intermediate profile in relation to concordant predictions.

Trabaud MA, Icard V, Scholtes C, Perpoint T, Koffi J, Cotte L, Makhloufi D, Tardy JC, André P.

J Med Virol. 2012 Mar;84(3):402-13. doi: 10.1002/jmv.23209.

PMID:
22246825
13.

Improved V3 genotyping with duplicate PCR amplification for determining HIV-1 tropism.

Raymond S, Recordon-Pinson P, Saliou A, Delobel P, Nicot F, Descamps D, Marcelin AG, Flandre P, Calvez V, Masquelier B, Izopet J; ANRS AC11 Resistance Study Group.

J Antimicrob Chemother. 2011 Sep;66(9):1972-5. doi: 10.1093/jac/dkr224. Epub 2011 Jun 14.

14.

Concordance between two phenotypic assays and ultradeep pyrosequencing for determining HIV-1 tropism.

Saliou A, Delobel P, Dubois M, Nicot F, Raymond S, Calvez V, Masquelier B, Izopet J; ANRS AC11 Resistance Study Group.

Antimicrob Agents Chemother. 2011 Jun;55(6):2831-6. doi: 10.1128/AAC.00091-11. Epub 2011 Apr 4.

15.

HIV-1 load comparison using four commercial real-time assays.

Bourlet T, Signori-Schmuck A, Roche L, Icard V, Saoudin H, Trabaud MA, Tardy JC, Morand P, Pozzetto B, Ecochard R, André P.

J Clin Microbiol. 2011 Jan;49(1):292-7. doi: 10.1128/JCM.01688-10. Epub 2010 Nov 10.

16.

Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France.

Descamps D, Chaix ML, Montes B, Pakianather S, Charpentier C, Storto A, Barin F, Dos Santos G, Krivine A, Delaugerre C, Izopet J, Marcelin AG, Maillard A, Morand-Joubert L, Pallier C, Plantier JC, Tamalet C, Cottalorda J, Desbois D, Calvez V, Brun-Vezinet F, Masquelier B, Costagliola D; ANRS AC11 Resistance Study Group.

J Antimicrob Chemother. 2010 Dec;65(12):2620-7. doi: 10.1093/jac/dkq380. Epub 2010 Oct 21.

17.

HIV-1 infection: functional competition between gp41 and interleukin-2.

Sanhadji K, Tardy JC, Touraine JL.

C R Biol. 2010 Aug;333(8):608-12. doi: 10.1016/j.crvi.2009.01.009. Epub 2010 Jun 23.

PMID:
20688281
18.

Evaluation of the genotypic prediction of HIV-1 coreceptor use versus a phenotypic assay and correlation with the virological response to maraviroc: the ANRS GenoTropism study.

Recordon-Pinson P, Soulié C, Flandre P, Descamps D, Lazrek M, Charpentier C, Montes B, Trabaud MA, Cottalorda J, Schneider V, Morand-Joubert L, Tamalet C, Desbois D, Macé M, Ferré V, Vabret A, Ruffault A, Pallier C, Raymond S, Izopet J, Reynes J, Marcelin AG, Masquelier B; ANRS AC11 Resistance Study Group.

Antimicrob Agents Chemother. 2010 Aug;54(8):3335-40. doi: 10.1128/AAC.00148-10. Epub 2010 Jun 7.

19.

Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients.

Marcelin AG, Flandre P, Descamps D, Morand-Joubert L, Charpentier C, Izopet J, Trabaud MA, Saoudin H, Delaugerre C, Tamalet C, Cottalorda J, Bouvier-Alias M, Bettinger D, Dos Santos G, Ruffault A, Alloui C, Henquell C, Rogez S, Barin F, Signori-Schmuck A, Vallet S, Masquelier B, Calvez V; ANRS AC11 Resistance Study Group.

Antimicrob Agents Chemother. 2010 Jan;54(1):72-7. doi: 10.1128/AAC.01051-09. Epub 2009 Nov 9.

20.

Prediction of the virological response to etravirine in clinical practice: Comparison of three genotype algorithms.

Cotte L, Trabaud MA, Tardy JC, Brochier C, Gilibert RP, Miailhes P, Trépo C, André P.

J Med Virol. 2009 Apr;81(4):672-7. doi: 10.1002/jmv.21461.

PMID:
19235860
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk